Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose-Reference-Cited by-同舟云学术

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

Published:2022-05-09 Issue:6 Volume:23 Page:940-946
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Lustig Yaniv,Gonen Tal,Meltzer Lilac,Gilboa Mayan,Indenbaum Victoria,Cohen Carmit,Amit Sharon,Jaber Hanaa,Doolman Ram,Asraf Keren,Rubin Carmit,Fluss Ronen,Mendelson Ella,Freedman Laurence^ORCID,Regev-Yochay Gili^ORCID,Kreiss Yitshak

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://www.nature.com/articles/s41590-022-01212-3.pdf

Reference22 articles.

1. Abu-Raddad, L. J., Chemaitelly, H. & Butt, A. A. Effectiveness of the BNT162b2 COVID-19 vaccine against the B.1.1.7 and B.1.351 variants. N. Engl. J. Med. 385, 187–189 (2021).

2. Bernal, J. L. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at medRxiv https://doi.org/10.1101/2021.03.01.21252652 (2021).

3. Chemaitelly, H. et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N. Engl. J. Med. 385, e83 (2021).

4. Dagan, N. et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med. 384, 1970 (2021).

5. Haas, E. J. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397, 1819–1829 (2021).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody responses post-booster COVID-19 vaccination: Insights from a single-center prospective cohort study;Diagnostic Microbiology and Infectious Disease;2024-10

2. Probing quantum causality with geometric asymmetry in spatial-temporal correlations;Science China Information Sciences;2024-08-19

3. Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera;Vaccines;2024-08-13

4. The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies;MedComm;2024-07-29

5. Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul;Scientific Reports;2024-07-22